50V Stock Chart & Stats
€0.01
€0.00(0.00%)
At close: 4:00 PM EST
€0.01
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.04
Previous CloseN/A
Volume0.00
Average Volume (3M)38.74K
Market Cap
€3.17M
Enterprise Value€45.75M
Total Cash (Recent Filing)€1.92M
Total Debt (Recent Filing)€7.98M
Price to Earnings (P/E)―
Beta-75.57
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding204,569,100
10 Day Avg. Volume50,263
30 Day Avg. Volume38,740
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)-5.45
Price to Sales (P/S)1.34
P/FCF Ratio-14.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Digital Health Business ModelAino addresses a recurring employer need by combining digital tools, health-related processes, and reporting for HR and occupational-health stakeholders. This business model can support repeat organizational use and gives the company a defined position within the growing digital health-management market.
Losses Narrowed From Earlier YearsAlthough Aino remains unprofitable, the improvement from the much deeper 2022 net margin indicates some progress in reducing the scale of losses. If maintained through further operating improvements, this could provide a foundation for eventual margin recovery and lower funding pressure.
Cash Burn Improved Versus 2022Operating cash outflow remains substantial, but the reduction from 2022 shows that cash consumption has improved over the longer period. Continued progress in this direction would extend financial runway, reduce reliance on external funding, and improve the viability of the operating model.
Bears Say
Declining Revenue And Weak MarginsA declining revenue base combined with a low gross margin and deeply negative EBIT indicates that Aino has not yet demonstrated operating leverage. Persistent margin pressure can limit reinvestment, weaken resilience, and make a durable path to profitability more difficult over the next several quarters.
Negative Equity And Thin Capital BaseNegative equity and debt exceeding total assets signal a highly constrained capital structure. This reduces financial flexibility, raises refinancing and funding risk if losses continue, and may restrict Aino’s ability to invest in product development or pursue growth without additional capital.
Ongoing Cash ConsumptionThe latest cash-flow deterioration shows that Aino is still consuming significant cash in its operations despite earlier improvement. Continued negative free cash flow can increase dependence on external financing, heighten dilution or refinancing risk, and constrain strategic choices over the medium term.
50V FAQ
What was Aino Health AB’s price range in the past 12 months?
Aino Health AB lowest stock price was <€0.01 and its highest was €0.04 in the past 12 months.
What is Aino Health AB’s market cap?
Aino Health AB’s market cap is €3.17M.
When is Aino Health AB’s upcoming earnings report date?
Aino Health AB’s upcoming earnings report date is Nov 12, 2026 which is in 20 days.
How were Aino Health AB’s earnings last quarter?
Aino Health AB released its earnings results on Aug 17, 2026. The company reported -€0.001 earnings per share for the quarter.
Is Aino Health AB overvalued?
According to Wall Street analysts Aino Health AB’s price is currently Overvalued.
Does Aino Health AB pay dividends?
Aino Health AB does not currently pay dividends.
What is Aino Health AB’s EPS estimate?
Aino Health AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aino Health AB have?
Aino Health AB has 204,569,100 shares outstanding.
What happened to Aino Health AB’s price movement after its last earnings report?
Aino Health AB reported an EPS of -€0.001 in its last earnings report. Following the earnings report the stock price went down -50%.
Which hedge fund is a major shareholder of Aino Health AB?
Currently, no hedge funds are holding shares in DE:50V
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aino Health AB
Aino Health AB (publ), a Swedish company based in Stockholm, specializes in delivering comprehensive corporate health management solutions to both private and public organizations throughout Finland. Their flagship offering is HealthManager, a Software-as-a-Service (SaaS) platform equipped with tools for health surveys, analytical insights, exposure checks, and compliance with security and GDPR regulations, along with an integrated e-learning module. Beyond the software, Aino Health provides a range of additional services, including telemedicine, professional support (such as analytics, management/employee guidance, and well-being programs), and onboarding assistance covering project management, implementation, and training. The company also extends its services to a diverse network of partners, including occupational health providers, insurance companies, IT firms, HR/payroll service centers, and various healthcare practitioners.
Technical Analysis
Humana AB
―
Q-linea AB
―
Kontigo Care AB
―
Surgical Science Sweden AB
―
Physitrack Limited
―